{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:39:22Z","timestamp":1775183962257,"version":"3.50.1"},"reference-count":150,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/nrl.0b013e3181870aa2","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T08:13:51Z","timestamp":1231316031000},"page":"21-33","source":"Crossref","is-referenced-by-count":69,"title":["Paraneoplastic Neurological Syndromes"],"prefix":"10.1097","volume":"15","author":[{"given":"Thomas B.","family":"Toothaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210211","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system.","volume":"349","author":"Darnell","year":"2003","journal-title":"N Eng J Med"},{"key":"R2-4-20210211","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1073\/pnas.93.10.4529","article-title":"Onconeural antigens and paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.","volume":"93","author":"Darnell","year":"1996","journal-title":"Proc Natl Acd Sci USA"},{"key":"R3-4-20210211","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulin, cyclophosphamide, and methylprednisolone.","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-4-20210211","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mpo.1139","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features\u2013a report from the Children's Cancer Group.","volume":"36","author":"Cooper","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R5-4-20210211","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1750-3639.1993.tb00747.x","article-title":"Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome.","volume":"3","author":"Rosenblum","year":"1993","journal-title":"Brain Pathol"},{"key":"R6-4-20210211","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4065\/78.11.1363","article-title":"Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis.","volume":"78","author":"Lawn","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R7-4-20210211","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archneur.61.1.30","article-title":"Paraneoplastic neurologic disorders.","volume":"61","author":"Darnell","year":"2004","journal-title":"Arch Neurol"},{"key":"R8-4-20210211","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.neuro.24.1.239","article-title":"Paraneoplastic neurologic disease antigens.","volume":"24","author":"Musunuru","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"R9-4-20210211","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1523\/JNEUROSCI.11-05-01224.1991","article-title":"Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons and neuroectodermal tumors.","volume":"11","author":"Darnell","year":"1991","journal-title":"J Neurosci"},{"key":"R10-4-20210211","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann Neurol"},{"key":"R11-4-20210211","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004150050054","article-title":"Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients.","volume":"244","author":"Drlicek","year":"1997","journal-title":"J Neurol"},{"key":"R12-4-20210211","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.1997.15.8.2866","article-title":"Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.","volume":"15","author":"Graus","year":"1997","journal-title":"J Clin Oncol"},{"key":"R13-4-20210211","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19871101)60:9<2275::AID-CNCR2820600929>3.0.CO;2-3","article-title":"Neurologic disorders in patients with small cell lung cancer.","volume":"60","author":"Sculier","year":"1987","journal-title":"Cancer"},{"key":"R14-4-20210211","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/cncr.20043","article-title":"Neurologic disorders in 432 consecutive patients with small cell lung carcinoma.","volume":"100","author":"Suete","year":"2004","journal-title":"Cancer"},{"key":"R15-4-20210211","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma.","volume":"10","author":"Vernino","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"suppl1","key":"R16-4-20210211","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/ana.410370705","article-title":"Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.","volume":"37","author":"Latov","year":"1995","journal-title":"Ann Neurol"},{"key":"R17-4-20210211","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2003-41134","article-title":"Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.","volume":"23","author":"Bataller","year":"2003","journal-title":"Sem in Neurol"},{"key":"R18-4-20210211","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/jnnp.2004.038489","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes: editorial commentary.","volume":"75","author":"Greenlee","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-4-20210211","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes.","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-4-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-2-22","article-title":"Paraneoplastic neurological syndromes.","volume":"2","author":"Honnorat","year":"2007","journal-title":"Orphanet J of Rare Dis"},{"key":"R21-4-20210211","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/01.WNL.0000129983.06983.4E","article-title":"Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.","volume":"63","author":"Linke","year":"2004","journal-title":"Neurology"},{"key":"R22-4-20210211","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","article-title":"FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.","volume":"127","author":"Younes-Mhenni","year":"2004","journal-title":"Brain"},{"key":"R23-4-20210211","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","article-title":"Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.","volume":"13","author":"Vedeler","year":"2006","journal-title":"European J Neurol"},{"key":"R24-4-20210211","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.crad.2007.06.005","article-title":"Imaging in the investigation of paraneoplastic syndromes.","volume":"62","author":"Rutherford","year":"2007","journal-title":"Clinical Radiology"},{"key":"R25-4-20210211","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu associated paraneoplastic encephalomyelitis: analysis of 200 patients.","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"R26-4-20210211","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu associated paraneoplastic encephalomyelitis\/sensory neuropathy: a clinical study of 71 patients.","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine"},{"key":"R27-4-20210211","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/jnnp.62.3.276","article-title":"Spontaneous neurological improvement in anti-Hu associated encephalomyelitis.","volume":"62","author":"Byrne","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-4-20210211","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.1999.tb00226.x","article-title":"Paraneoplastic neurologic syndromes: pathogenesis and physiopathology.","volume":"9","author":"Dalmau","year":"1999","journal-title":"Brain Pathol"},{"key":"R29-4-20210211","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminoncol.2006.03.008","article-title":"Paraneoplastic syndromes affecting the nervous system.","volume":"33","author":"Darnell","year":"2006","journal-title":"Semin Oncol"},{"key":"R30-4-20210211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0140-6736(93)92485-C","article-title":"Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies.","volume":"341","author":"Darnell","year":"1993","journal-title":"Lancet"},{"key":"R31-4-20210211","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coi.2004.07.009","article-title":"Neuroimmunology of the paraneoplastic neurological degenerations.","volume":"16","author":"Roberts","year":"2004","journal-title":"Curr Opin Immonol"},{"key":"R32-4-20210211","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.410270515","article-title":"Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer: a quantitative western blot analysis.","volume":"27","author":"Dalmau","year":"1990","journal-title":"Ann Neurol"},{"key":"R33-4-20210211","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.40.7.1085","article-title":"Auto-antibody synthesis in the central nervous system of patients with paraneoplastic syndromes.","volume":"40","author":"Furneaux","year":"1990","journal-title":"Neurology"},{"key":"R34-4-20210211","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/mus.880090608","article-title":"Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG.","volume":"9","author":"Kim","year":"1986","journal-title":"Muscle Nerve"},{"key":"R35-4-20210211","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse.","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"R36-4-20210211","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-510X(91)90198-G","article-title":"Effect of intraventricular injection of anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.","volume":"106","author":"Graus","year":"1991","journal-title":"J Neurol Sci"},{"key":"R37-4-20210211","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.45.10.1873","article-title":"Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice.","volume":"45","author":"Sillevis Smitt","year":"1995","journal-title":"Neurology"},{"key":"R38-4-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2003.08.006","article-title":"Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary cultured neurons.","volume":"217","author":"Tanaka","year":"2004","journal-title":"J Neurol Sci"},{"key":"R39-4-20210211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I","article-title":"Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.","volume":"47","author":"Albert","year":"2000","journal-title":"Ann Neurol"},{"key":"R40-4-20210211","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","article-title":"Limbic encephalitis and its association with carcinoma.","volume":"91","author":"Corsellis","year":"1968","journal-title":"Brain"},{"key":"R41-4-20210211","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumor association in 50 patients.","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"R42-4-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R43-4-20210211","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM199906103402303","article-title":"A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.","volume":"340","author":"Voltz","year":"1999","journal-title":"N Engl J Med"},{"key":"R44-4-20210211","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2 associated encephalitis.","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"R45-4-20210211","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis, and treatment.","volume":"13","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"The Neurologist"},{"key":"R46-4-20210211","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"key":"R47-4-20210211","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2006.04.002","article-title":"Herpes simplex encephalitis.","volume":"71","author":"Whitley","year":"2006","journal-title":"Antiviral Res"},{"key":"R48-4-20210211","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.nrl.0000259483.70041.55","article-title":"Autoimmune encephalopathies.","volume":"13","author":"Vernino","year":"2007","journal-title":"The Neurologist"},{"key":"R49-4-20210211","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"R50-4-20210211","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"R51-4-20210211","first-page":"691","article-title":"Les affections parenchymateuse du cervelet et leur signification du point de vue de l'anatomie et de la physiologie de cet organe.","volume":"38","author":"Brouwer","year":"1938","journal-title":"J Belge Neurol Pscychiat"},{"key":"R52-4-20210211","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","article-title":"Paraneoplastic cerebellar degeneration I. A clinical analysis of 55 anti-Yo antibody-positive patients.","volume":"42","author":"Peterson","year":"1992","journal-title":"Neurol"},{"key":"R53-4-20210211","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1212\/WNL.42.10.1938","article-title":"Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease.","volume":"42","author":"Hammack","year":"1992","journal-title":"Neurol"},{"key":"R54-4-20210211","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"R55-4-20210211","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1023931501503","article-title":"Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature.","volume":"63","author":"Widdess-Walsh","year":"2003","journal-title":"J Neurooncol"},{"key":"R56-4-20210211","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-006-9198-x","article-title":"Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.","volume":"81","author":"Phuphanich","year":"2007","journal-title":"J Neurooncol"},{"key":"R57-4-20210211","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.42.10.1944","article-title":"Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome.","volume":"42","author":"Clouston","year":"1992","journal-title":"Neurol"},{"key":"R58-4-20210211","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","article-title":"Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.","volume":"120","author":"Mason","year":"1997","journal-title":"Brain"},{"key":"R59-4-20210211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/WCO.0b013e3280126b51","article-title":"An update on opsoclonus.","volume":"20","author":"Wong","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"R60-4-20210211","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1043454204272560","article-title":"Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.","volume":"22","author":"Tate","year":"2005","journal-title":"J Pediatr Oncol Nurs"},{"key":"R61-4-20210211","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mpo.1138","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineural antibodies-a report from the Children's Cancer Group study.","volume":"36","author":"Rudnick","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R62-4-20210211","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes.","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"R63-4-20210211","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","article-title":"Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.","volume":"28","author":"Pranzatelli","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R64-4-20210211","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.20539","article-title":"Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.","volume":"58","author":"Blaes","year":"2005","journal-title":"Ann Neurol"},{"key":"R65-4-20210211","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2005.08.018","article-title":"Functional characterization of autoantibodies from patients with pediatric opsoclonus-myoclonus syndrome.","volume":"170","author":"Korfei","year":"2005","journal-title":"J Neuroimmol"},{"key":"R66-4-20210211","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/1097-0142(197602)37:2<846::AID-CNCR2820370233>3.0.CO;2-L","article-title":"Favorable prognosis for survival in children with coincident opso-myolconus and neuroblastoma.","volume":"37","author":"Altman","year":"1976","journal-title":"Cancer"},{"key":"R67-4-20210211","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.","volume":"29","author":"Luque","year":"1991","journal-title":"Ann Neurol"},{"key":"R68-4-20210211","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.10518","article-title":"Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.","volume":"53","author":"Pittock","year":"2003","journal-title":"Ann Neurol"},{"key":"R69-4-20210211","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"R70-4-20210211","first-page":"106","article-title":"Stiff-person syndrome.","volume":"7","author":"Lockman","year":"2007","journal-title":"Pract Neurol"},{"key":"R71-4-20210211","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.nrl.0000126587.37087.1a","article-title":"Stiff-person syndrome.","volume":"10","author":"Murinson","year":"2004","journal-title":"Neurologist"},{"key":"R72-4-20210211","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00936885","article-title":"Stiff-man syndrome: neurophysiological findings in eight patients.","volume":"242","author":"Meinck","year":"1995","journal-title":"J Neurol"},{"key":"R73-4-20210211","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0025-6196(12)65339-7","article-title":"Stiff-man syndrome up-dated.","volume":"64","author":"Lorish","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"R74-4-20210211","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.","volume":"318","author":"Solimena","year":"1988","journal-title":"N Engl J Med"},{"key":"R75-4-20210211","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.WNL.0000123694.64121.D5","article-title":"Paraneoplastic \u201cstiff person syndrome\u201d with metastatic adenocarcinoma and anti-Ri antibodies.","volume":"62","author":"McCabe","year":"2004","journal-title":"Neurology"},{"key":"R76-4-20210211","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0896-6273(00)81165-4","article-title":"Autoimmunity to gephyrin in stiff-man syndrome.","volume":"26","author":"Butler","year":"2000","journal-title":"Neuron"},{"key":"R77-4-20210211","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/B:NEON.0000003754.34527.f2","article-title":"Anti-GAD antibody positive stiff-limb syndrome in multiple myeloma.","volume":"65","author":"Schiff","year":"2003","journal-title":"J neurooncol"},{"key":"R78-4-20210211","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(05)66376-3","article-title":"Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin.","volume":"365","author":"Sommer","year":"2005","journal-title":"Lancet"},{"issue":"suppl 1","key":"R79-4-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-005-1105-4","article-title":"The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.","volume":"252","author":"Dalakas","year":"2005","journal-title":"J Neurol"},{"key":"R80-4-20210211","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immunoglobulin for stiff-person syndrome.","volume":"345","author":"Dalakas","year":"2001","journal-title":"N Engl J Med"},{"key":"R81-4-20210211","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplastic accompaniments.","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann Neurol"},{"key":"R82-4-20210211","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11940-005-0007-1","article-title":"Paraneoplastic retinopathy\/optic neuropathy.","volume":"7","author":"Damek","year":"2005","journal-title":"Curr Treat Options Neurol"},{"key":"R83-4-20210211","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00019052-200402000-00003","article-title":"Neuro-ophthalmology and paraneoplastic syndromes.","volume":"17","author":"Bataller","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R84-4-20210211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0165-5728(02)00314-4","article-title":"Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal call apoptotic death via the caspase 9- and caspase 3-dependent pathway.","volume":"132","author":"Shiraga","year":"2002","journal-title":"J Neuroimmunol"},{"key":"R85-4-20210211","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9394(02)01633-1","article-title":"Antirecoverin antibody in the aqueous humor of patients with cancer-associated retinopathy.","volume":"134","author":"Ohguro","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R86-4-20210211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-4-5","article-title":"Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.","volume":"4","author":"Adamus","year":"2004","journal-title":"BMC Ophthalmol"},{"key":"R87-4-20210211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-5728(99)00163-0","article-title":"Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy.","volume":"103","author":"Kikuchi","year":"2000","journal-title":"J Neuroimmunol"},{"key":"R88-4-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00041327-200109000-00003","article-title":"The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.","volume":"21","author":"Eichen","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"R89-4-20210211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-5728(01)00427-1","article-title":"Molecular cloning and characterization of human PTB-like protein: a possible retinal autoantigen of cancer-associated retinopathy.","volume":"120","author":"Tateiwa","year":"2001","journal-title":"J Neuroimmunol"},{"key":"R90-4-20210211","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0002-9394(00)00925-9","article-title":"Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon cancer.","volume":"131","author":"Jacobson","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R91-4-20210211","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ijc.22384","article-title":"Mitofilin and titin as target antigens in melanoma-associated retinopathy.","volume":"120","author":"Pf\u00f6hler","year":"2006","journal-title":"Int J Cancer"},{"key":"R92-4-20210211","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic optic neuritis with retinitis defined by CRMP-5-IgG.","volume":"54","author":"Cross","year":"2003","journal-title":"Ann Neurol"},{"key":"R93-4-20210211","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis.","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"R94-4-20210211","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00314238","article-title":"Motor neuron disease and malignancies: results of a population-based study.","volume":"235","author":"Chi\u00f2","year":"1988","journal-title":"J Neurol"},{"key":"R95-4-20210211","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.30.5.453","article-title":"Epidemiology of amyotrophic lateral sclerosis: 1. a case control comparison based on ALS deaths.","volume":"30","author":"Kurtzke","year":"1980","journal-title":"Neurology"},{"key":"R96-4-20210211","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/jnnp.2006.097774","article-title":"Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease.","volume":"78","author":"Stich","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R97-4-20210211","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/(SICI)1097-4598(199807)21:7<943::AID-MUS14>3.0.CO;2-R","article-title":"Paraneoplastic motor neuron disease with type 1 purkinje cell antibodies.","volume":"21","author":"Khwaja","year":"1998","journal-title":"Muscle Nerve"},{"key":"R98-4-20210211","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410400118","article-title":"Motor neuron disease: a paraneoplastic process associated with anti-Hu antibody and small-cell lung carcinoma.","volume":"40","author":"Verma","year":"1996","journal-title":"Ann Neurol"},{"key":"R99-4-20210211","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410410608","article-title":"Motor neuron syndromes in cancer patients.","volume":"41","author":"Forsyth","year":"1997","journal-title":"Ann Neurol"},{"key":"R100-4-20210211","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1212\/WNL.42.5.1101","article-title":"Amyotrophic lateral sclerosis and lymphoma: bone marrow examination and other diagnostic tests.","volume":"42","author":"Rowland","year":"1992","journal-title":"Neurology"},{"key":"R101-4-20210211","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1212\/WNL.48.6.1671","article-title":"Lymphoproliferative disorders and motor neuron disease: an update.","volume":"48","author":"Gordon","year":"1997","journal-title":"Neurology"},{"key":"R102-4-20210211","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(06)70679-2","article-title":"Peripheral nervous system involvement in patients with cancer.","volume":"6","author":"Antoine","year":"2007","journal-title":"Lancet Neurol"},{"key":"R103-4-20210211","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ana.410440620","article-title":"Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy.","volume":"44","author":"Molinuevo","year":"1998","journal-title":"Ann Neurol"},{"key":"R104-4-20210211","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.wco.0000173462.17135.ee","article-title":"Paraneoplastic syndromes of the peripheral nerves.","volume":"18","author":"Rudnicki","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"R105-4-20210211","first-page":"1138","article-title":"Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies: a clinical and electrophysiologic study of 20 patients.","volume":"124","author":"Camdessanche","year":"2002","journal-title":"Brain"},{"key":"R106-4-20210211","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clinph.2004.07.012","article-title":"Anti-Hu antibody neuropathy: a clinical, eletrophysiologic, and pathologic study.","volume":"116","author":"Oh","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"R107-4-20210211","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mus.20100","article-title":"Clinical features and pathophysiologic basis of sensory neuronopathies (ganglionopathies).","volume":"30","author":"Kuntzer","year":"2004","journal-title":"Muscle Nerve"},{"key":"R108-4-20210211","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","article-title":"Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy.","volume":"49","author":"Antoine","year":"2001","journal-title":"Ann Neurol"},{"key":"R109-4-20210211","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/01.WNL.0000176296.79088.9A","article-title":"Malignant transformation in polyneuropathy associated with monoclonal gammopathy.","volume":"64","author":"Eurelings","year":"2005","journal-title":"Neurology"},{"key":"R110-4-20210211","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jnnp.2005.071175","article-title":"Peripheral neuropathies in Waldenstr\u00f6m's macroglobulinemia.","volume":"77","author":"Levine","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R111-4-20210211","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome.","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"R112-4-20210211","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.clinph.2006.03.008","article-title":"Neuromyotonia.","volume":"117","author":"Maddison","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"R113-4-20210211","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.20081","article-title":"Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies.","volume":"30","author":"L\u00f6scher","year":"2004","journal-title":"Muscle Nerve"},{"key":"R114-4-20210211","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.1139","article-title":"Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement.","volume":"24","year":"2001","journal-title":"Muscle Nerve"},{"key":"R115-4-20210211","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00415-004-0331-5","article-title":"Myokymia and neuromyotonia 2004.","volume":"251","author":"Gutmann","year":"2004","journal-title":"J Neurol"},{"key":"R116-4-20210211","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves.","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"R117-4-20210211","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archneur.57.4.527","article-title":"Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.","volume":"57","author":"Mygland","year":"2000","journal-title":"Arch Neurol"},{"key":"R118-4-20210211","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/mus.1078","article-title":"Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkin's disease.","volume":"24","author":"Lahrmann","year":"2001","journal-title":"Muscle Nerve"},{"key":"R119-4-20210211","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/014107680009300709","article-title":"Wriggling muscles as a sign of lung carcinoma.","volume":"93","author":"Direkze","year":"2000","journal-title":"J R Soc Med"},{"key":"R120-4-20210211","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0303-8467(99)00037-2","article-title":"Neuromyotonia, myoclonus, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies).","volume":"101","author":"Toepfer","year":"1999","journal-title":"Clin Neurol Neurosurg"},{"key":"R121-4-20210211","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s004150050419","article-title":"Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin.","volume":"246","author":"van den Berg","year":"1999","journal-title":"J Neurol"},{"key":"R122-4-20210211","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-2004-830900","article-title":"Lambert-Eaton myasthenic syndrome.","volume":"24","author":"Mareska","year":"2004","journal-title":"Semin Neurol"},{"key":"R123-4-20210211","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1196\/annals.1254.065","article-title":"Lambert-Eaton myasthenic syndrome, diagnosis and treatment.","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"R124-4-20210211","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/jnnp.73.6.766","article-title":"Differences in distribution of muscle weakness between myasthenia gravis and the Lambert Eaton myasthenic syndrome.","volume":"73","author":"Wirtz","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R125-4-20210211","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0303-8467(02)00054-9","article-title":"Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases.","volume":"104","author":"Wirtz","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"R126-4-20210211","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.48.Suppl_5.23S","article-title":"Serological profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome.","volume":"48","author":"Lennon","year":"1997","journal-title":"Neurology"},{"key":"R127-4-20210211","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/cs1020475","article-title":"The immunopathogenesis of paraneoplastic neurological syndromes.","volume":"102","author":"Sutton","year":"2002","journal-title":"Clin Sci"},{"key":"R128-4-20210211","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.40.10.1552","article-title":"Response of Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma.","volume":"40","author":"Chalk","year":"1990","journal-title":"Neurology"},{"key":"R129-4-20210211","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/WNL.54.3.603","article-title":"A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.","volume":"54","author":"Sanders","year":"2000","journal-title":"Neurology"},{"key":"R130-4-20210211","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","article-title":"Clinical evaluation and management of myasthenia gravis.","volume":"29","author":"Keesey","year":"2004","journal-title":"Muscle Nerve"},{"key":"R131-4-20210211","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1196\/annals.1254.025","article-title":"The role of thymomas in the development of myasthenia gravis.","volume":"998","author":"Marx","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"R132-4-20210211","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.293.15.1906","article-title":"Does this patient have myasthenia gravis?","volume":"293","author":"Scherer","year":"2005","journal-title":"JAMA"},{"key":"R133-4-20210211","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/mus.1140","article-title":"Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome.","volume":"24","year":"2001","journal-title":"Muscle Nerve"},{"key":"R134-4-20210211","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future.","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"R135-4-20210211","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00415-006-0429-z","article-title":"Paraneoplastic diseases associated with thymoma.","volume":"254","author":"Evoli","year":"2007","journal-title":"J Neurol"},{"key":"R136-4-20210211","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.2006.00606.x","article-title":"Clinical aspects of neuromuscular transmission disorders.","volume":"183","author":"Evoli","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"R137-4-20210211","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"R138-4-20210211","first-page":"49","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"24","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"R139-4-20210211","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jtcvs.2007.05.015","article-title":"Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma.","volume":"134","author":"Kim","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R140-4-20210211","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11926-007-0044-8","article-title":"Inflammatory muscle disease: clinical presentation and assessment of patients.","volume":"9","author":"Alexanderson","year":"2007","journal-title":"Curr Rheumatol Reports"},{"key":"R141-4-20210211","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11926-007-0047-5","article-title":"Advances in the immunobiology and treatment of inflammatory myopathies.","volume":"9","author":"Dalakas","year":"2007","journal-title":"Curr Rheumatol Reports"},{"key":"R142-4-20210211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08916930600622132","article-title":"Update on idiopathic inflammatory myopathies.","volume":"39","author":"Briani","year":"2006","journal-title":"Autoimmunity"},{"key":"R143-4-20210211","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"R144-4-20210211","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"R145-4-20210211","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy, a population based cohort study.","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"R146-4-20210211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"key":"R147-4-20210211","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","article-title":"Tumor antigen markers for the detection of solid cancers in inflammatory myopathies.","volume":"14","author":"Amoura","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R148-4-20210211","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis.","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R149-4-20210211","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1634\/theoncologist.11-3-292","article-title":"Managing paraneoplastic neurological disorders.","volume":"11","author":"Beukelaar","year":"2006","journal-title":"Oncologist"},{"key":"R150-4-20210211","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2006.10.003","article-title":"Autonomic paraneoplastic neurological syndromes.","volume":"6","author":"Lorusso","year":"2007","journal-title":"Autoimmun Rev"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00127893-200901000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:23:52Z","timestamp":1618035832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-200901000-00004"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e3181870aa2","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}